Product Information
BUPRENORPHINE 2 MG TABLET SL is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.2629 per EA under NDC 42858050103. Its NADAC has been published 432 times since Mar 21, 2018.
Strength
2 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858050103
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207276On Market Since
10/25/2017
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 2 MG TABLET SL has been published 432 times since Mar 21, 2018, and over the history we have for it it has declined 72.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2629 per EA |
|---|---|
| All-time high | $0.9445 (Apr 11, 2018) |
| All-time low | $0.2629 (Jun 17, 2026) |
| 52-week high | $0.3346 |
| 52-week low | $0.2629 |
| Median price | $0.4651 |
| Average price | $0.4977 |
| Largest weekly change | +42.0% (Aug 21, 2024) |
| Weeks tracked | 432 |
| Tracking since | Mar 21, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BUPRENORPHINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 2 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 2 MG TABLET SL, manufactured by Rhodes Pharmaceuticals L.P., is $0.2629 per EA (NDC 42858050103), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 2 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 2 MG TABLET SL has declined 72.2%. It has been tracked across 432 weekly CMS publications since Mar 21, 2018.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 2 MG TABLET SL?
Since Mar 21, 2018, the NADAC for BUPRENORPHINE 2 MG TABLET SL has ranged from a low of $0.2629 (Jun 17, 2026) to a high of $0.9445 (Apr 11, 2018), with a median of $0.4651 per EA.
Are there cheaper alternatives to BUPRENORPHINE 2 MG TABLET SL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUPRENORPHINE 2 MG TABLET SL, so no direct lower-cost alternative is listed.
Who manufactures BUPRENORPHINE 2 MG TABLET SL?
BUPRENORPHINE 2 MG TABLET SL (NDC 42858050103) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification